Synchrotron Services for Industrial Scientists
Welcome to the Industrial Liaison Office. We are a group of specialist scientists with a diverse range of expertise, all dedicated to supporting scientists and researchers from a variety of industries access the facilities here at Diamond. The team has an assorted range of backgrounds and each member is a specialist in a different technique. We are therefore able to provide a multi-disciplinary approach to solving research and development problems.
To find out more about how we can help with your project, the technique you are interested in, the industry sector you are from, or simply find out more about the service we can offer, click on one of the buttons below.
If you would like to discuss your requirements with us, please use the contact details on this page to get in touch.
Featured Case Studies
The ability to modulate drug delivery at therapeutically effective doses over a sustained period of time, in vivo, is very challenging. In the case of poorly water-soluble drugs this requires a carefully designed matrix to manage and maintain their controlled release.
Lipid cubic phase carriers offer an effective way to transport both small molecules and larger proteins through oral and parenteral routes (those outside of the digestive tract), as well as local delivery via subcutaneous and intramuscular routes. Complex interactions between the drug and the lipid matrix govern the release profile; for hydrophilic drugs, release can be very fast. The carriers can also be compromised by naturally occurring lipolytic enzymes which act to break down the lipid microstructure.Read more...
T-cell receptors (TCRs) are protein complexes found on the surface
of human T-cells responsible for recognising a large variety of
antigen peptides. When a TCR binds to a specific antigen it triggers
an immune response that is part of the adaptive immune system
and prevents the growth of pathogens.
There is great interest in using this natural defence system for
cancer immunotherapy by producing modified TCRs that bind
cancer antigens and activate an immune response against
Poor air quality and reduced greenhouse gas emissions are at the forefront of public discussion, as well as being high on the agenda of worldwide policy makers. Many industries are embracing rapid changes in response, as is especially visible in the automotive sector, with the introduction of technologies such as gasoline particulate filters (GPFs). GPFs are positioned in a vehicle’s exhaust system and filter fine particulate matter (PM) produced by the engine. Recent legislation in places such as China, India and Europe will drive the adoption of GPFs on the majority of new gasoline, and hybrid electric, vehicles.
Whilst GPFs benefit public health and the environment by filtering out PM, they can also become gradually blocked by collected material. Captured carbonaceous particles (e.g. soot) can routinely oxidize away; however, inorganic PM (e.g. ash) typically remains in the filter for life, slowly blocking it and potentially reducing the fuel economy and power of the vehicle. Inorganic PM is predominantly derived from engine oil additive chemistry, which plays an important role in improving fuel economy, performance, and engine lifetime.Read more...